A Phase 3, Multi-Center, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients with Mild-to-Moderate Alzheimer's Disease on Donepezil

Study Status: 
Study Description: 

Please click on the study title and see the attached memo.

Study Coordinator(s): 

Scott McGinnis, MD

Martha Vander Vliet, RN

Tel:  617-732-8085

Dimebon Summary.doc56 KB